Exploring tumor-associated macrophages in glioblastoma: from diversity to therapy

Abstract Glioblastoma is the most aggressive and lethal cancer of the central nervous system, presenting substantial treatment challenges. The current standard treatment, which includes surgical resection followed by temozolomide and radiation, offers limited success. While immunotherapies, such as...

Full description

Bibliographic Details
Published in:npj Precision Oncology
Main Authors: Wenwen Zhao, Zhi Zhang, Mingyuan Xie, Feng Ding, Xiangrong Zheng, Shicheng Sun, Jianyang Du
Format: Article
Language:English
Published: Nature Portfolio 2025-05-01
Online Access:https://doi.org/10.1038/s41698-025-00920-x